Shares of Alexion Pharmaceuticals were soaring on Thursday and Friday after the company along with Amgen announced an agreement in a patent battle over blockbuster rare-disease drug Soliris. In a Wednesday filing, a judge with the Patent Trial and Appeal Board said that Alexion and Amgen which brought the suit, had asked to postpone the … Continue reading “Amgen and Alexion Pharmaceuticals Reach Agreement in Patent Battle”
Tag: amgen
Biotech & Pharma
Amgen Migraine Preventive Drug gets FDA Approval
The Food and Drug Administration has approved Amgen's drug Aimovig for the prevention of migraines.…
May 17, 2018
Biotech & Pharma
This Tweet From President Trump Just Sank Pharma Shares
Shares of many pharmaceutical companies saw a drop on Tuesday after President Trump made a…
March 7, 2017